Article
Haploid genetic screens identify genetic vulnerabilities to microtubule-targeting agents.
Molecular oncology - 1 Jun 2018
Gerhards Nora M, Blomen Vincent A, Mutlu Merve, Nieuwenhuis Joppe, Howald Denise, Guyader Charlotte, Jonkers Jos, Brummelkamp Thijn R, Rottenberg Sven
Abstract excerpt
The absence of biomarkers to accurately predict anticancer therapy response remains a major obstacle in clinical oncology. We applied a genome-wide loss-of-function screening approach in human haploid cells to characterize genetic vulnerabilities to classical microtubule-targeting agents. Using docetaxel and vinorelbine, two well-established chemotherapeutic agents, we sought to identify genetic alterations...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
